An experimental drug could help to improve movement for patients with spinal cord injuries.

NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom noted remarkable outcomes.

Larry Williams, a trial participant based in Philadelphia, Pennsylvania, shared with Fox News Digital that he’s been able to walk again after an accident that caused paralysis.

Williams, 58, was mountain biking on a small trail when he struck a tree. Although he was wearing a helmet, he "instantly broke" his C4 to C6 vertebrate (specific bones in the cervical spine).

He underwent spinal surgery , but was paralyzed for two weeks until his body began to "wake up" and regained some movement after starting therapy.

Williams was able to walk "a little bit" w

See Full Page